Alopecia Market Size, Scope And Growth 2025 To 2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

How Is the Alopecia Market Size Expected to Evolve From 2025 to 2029?
The alopecia market size has grown steadily in recent years. It will grow from $11.08 billion in 2024 to $11.48 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see steady growth in the next few years. It will grow to " $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12862&type=smp

Which Primary Drivers Are Expected to Shape the Future of the Alopecia Market?
The increase in the prevalence of hair loss is expected to propel the growth of the alopecia market going forward. Hair loss refers to the partial or complete loss of hair from areas where it usually grows. Alopecia treatment helps alopecia patients by addressing several issues with hair loss by extending hair regrowth, creating customized treatment plans, using combination therapies, and managing the physical aspect of hair loss, as these can have significant positive effects on a person's emotional well-being and quality of life. For instance, in April 2023, according to the data from the National Health Commission, a China-based executive department, over 250 million Chinese experienced hair loss, of which 42% were aged between 26 and 30. Furthermore, in February 2023, according to the Statistic Brain Research Institute, a US-based educational institute, approximately 40% of men will suffer from visible hair loss by age 35. Therefore, the increase in the prevalence of hair loss is driving the alopecia market.

How Is the Alopecia Market Categorized Based on Key Segments?
The alopeciamarket covered in this report is segmented –

1) By Type: Alopecia Areata; Androgenetic Alopecia; Alopecia Totalis; Traction Alopecia; Cicatricial Alopecia; Other Types
2) By Treatment: Pharmaceutical; Low Level Laser Therapy (LLLT) Devices; Hair Transplant; Regenerative Medicine; Other Treatments
3) By Gender: Male; Female
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
5) By End-User: Dermatology Clinics; Homecare Settings; Other End-Users

Subsegments:
1) By Alopecia Areata: Patchy Alopecia Areata; Persistent Patchy Alopecia Areata; Alopecia Universalis; Diffuse Alopecia Areata; Ophiasis
2) By Androgenetic Alopecia: Male Pattern Baldness; Female Pattern Hair Loss
3) By Alopecia Totalis: Complete Scalp Hair Loss
4) By Traction Alopecia: Frontal Traction Alopecia; Occipital Traction Alopecia
5) By Cicatricial Alopecia: Lichen Planopilaris; Discoid Lupus Erythematosus; Central Centrifugal Cicatricial Alopecia; Frontal Fibrosing Alopecia; Folliculitis Decalvans
6) By Other Types: Telogen Effluvium; Anagen Effluvium; Trichotillomania

Which Major Trends Are Expected to Define the Alopecia Market Through 2029?
Major companies operating in the alopecia market are focused on developing innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company, and Incyte, a US-based pharmaceutical company, unveiled their approval for luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

Who Are the Established and Emerging Companies Competing in the Alopecia Market?
Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

Get the detailed alopecia market report today
https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Which Region Is Expected to Dominate the Alopecia Market During the Forecast Period?
North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company